logo

For the Inventor, By the Inventor

Le Plessis Robinson, France

Synthelabo


USPTO Granted Patents = 252


Trademarks = 2

Forward Citations = 2,342

Loading Chart...
Loading Chart...

238 inventors (with patents filed for the assignee):

goldMedal Pascal George (44 out of 45 patents)

silverMedal Philippe Michel Manoury (37 out of 39 patents)

bronzeMedal Henry Najer (31 out of 31 patents)

4.  Don Pierre Giudicelli (24 out of 24 patents)

5.  Mireille Sevrin (21 out of 31 patents)

6.  Jonathan Reid Frost (20 out of 23 patents)

7.  Guy Rossey (18 out of 18 patents)

8.  Alexander E Wick (16 out of 16 patents)

9.  Thomas A Purcell (15 out of 15 patents)

10.  Jean-Pierre Kaplan (15 out of 15 patents)

11.  Jean Louis Binet (14 out of 21 patents)

12.  Daniel C Obitz (14 out of 14 patents)

13.  Jacques Froissant (13 out of 28 patents)

14.  Samir Jegham (12 out of 39 patents)

15.  Dennis C Bigg (12 out of 23 patents)


Core Competencies:
Pharmaceutical Compositions
Controlled Release
Therapeutic Uses
Oxazolidinone Derivatives
Serotonin Antagonists
Mizolastine
Alfuzosin
Benzofuran Derivatives
NSAIDs
Piperidine Derivatives
Ischemic Disorders
Glaucoma Treatment

252 patents:

1. 6214882 - Benzenesulphonamide derivatives, preparation thereof and therapeutical uses thereof (2001-04-10),
2. 6165507 - Slow-release pharmaceutical formulations containing mizolastine (2000-12-26),
3. 6149940 - Tablet with controlled release of alfuzosine chlorhydrate (2000-11-21),
4. 6143772 - Compounds derived from 3-(benzofuran-5-yl)oxazolidin-2-one, preparation (2000-11-07),
5. 6075021 - 1H-pyrido[3,4-b]indole-4-carboxamide derivatives, preparation and (2000-06-13),
6. 6069165 - Pharmaceutical compositions containing amisulpride and their therapeutic (2000-05-30),
7. 6063810 - 2-aminoethyl-benzofuran derivatives, preparation thereof and (2000-05-16),
8. 6060508 - Benzylamine derivatives, their preparation and their application in (2000-05-09),
9. D423784 - Toothbrush (2000-05-02),
10. 6056944 - Pharmaceutical compositions for oral use including an NSAID and ceramides (2000-05-02),
11. 6020352 - Treatment of ischemic disorders of the retina and optic nerve head (2000-02-01),
12. 5969146 - Oxazolidin-2-one derivatives, preparation method therefor and (1999-10-19),
13. D414937 - Toothbrush (1999-10-12),
14. 5958924 - Quinolein-2 (1H)-one derivatives as serotonin antagonists (1999-09-28),
15. 5929089 - 5-phenyl-3-(piperidin-4-yl)-1,3,4-oxadiazol-2(3H)-one derivatives for (1999-07-27),
Synthelabo is a leading pharmaceutical company specializing in the research, development, and production of innovative healthcare solutions. With a strong emphasis on scientific advancements and quality-driven practices, Synthelabo is dedicated to improving patient lives through its wide range of therapeutic offerings. Visit our website to learn more about our products, research pipeline, and commitment to promoting global health.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

252 Patents

#1 in Le Plessis Robinson

#98 in France

#3,457 in the World

Le Plessis Robinson, FR
Le Plessis Robinson, France

Synthelabo

Forward Citations = 2,342

238 inventors:

goldMedal Pascal George (44 out of 45 patents)

silverMedal Philippe Michel Manoury (37 out of 39 patents)

bronzeMedal Henry Najer (31 out of 31 patents)

4.  Don Pierre Giudicelli (24 out of 24 patents)

5.  Mireille Sevrin (21 out of 31 patents)

Please report any incorrect information to [email protected]
Loading…